These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 31886307)

  • 21. Defined Intestinal Regions Are Drained by Specific Lymph Nodes That Mount Distinct Th1 and Th2 Responses Against
    Mayer JU; Brown SL; MacDonald AS; Milling SW
    Front Immunol; 2020; 11():592325. PubMed ID: 33193437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections.
    Don TA; Bethony JM; Loukas A
    Int J Infect Dis; 2008 Nov; 12(6):e39-47. PubMed ID: 18571965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.
    Farias LP; Cardoso FC; Miyasato PA; Montoya BO; Tararam CA; Roffato HK; Kawano T; Gazzinelli A; Correa-Oliveira R; Coulson PS; Wilson RA; Oliveira SC; Leite LC
    PLoS Negl Trop Dis; 2010 Feb; 4(2):e597. PubMed ID: 20161725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.
    Ben-Yedidia T; Tarrab-Hazdai R; Schechtman D; Arnon R
    Infect Immun; 1999 Sep; 67(9):4360-6. PubMed ID: 10456875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with newly transformed Schistosoma mansoni schistosomula tegument elicits tegument damage, reduction in egg and parasite burden.
    Teixeira de Melo T; Michel de Araujo J; Do Valle Durães F; Caliari MV; Oliveira SC; Coelho PM; Fonseca CT
    Parasite Immunol; 2010; 32(11-12):749-59. PubMed ID: 21039615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.
    Zhang W; Ahmad G; Torben W; Noor Z; Le L; Damian RT; Wolf RF; White GL; Chavez-Suarez M; Podesta RB; Kennedy RC; Siddiqui AA
    J Infect Dis; 2010 Apr; 201(7):1105-12. PubMed ID: 20187746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvanted
    Perera DJ; Hassan AS; Jia Y; Ricciardi A; McCluskie MJ; Weeratna RD; Ndao M
    Front Immunol; 2020; 11():605288. PubMed ID: 33304354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection.
    Martins VP; Pinheiro CS; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Azevedo V; Castro-Borges W; Wilson RA; Oliveira SC
    Clin Dev Immunol; 2012; 2012():962538. PubMed ID: 22927873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection.
    Figueiredo BC; Assis NR; Morais SB; Ricci ND; Pinheiro CS; Martins VP; Bicalho RM; Da'dara AA; Skelly PJ; Oliveira SC
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3107. PubMed ID: 25144756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for parasite-induced PGE2 in IL-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni.
    Ramaswamy K; Kumar P; He YX
    J Immunol; 2000 Oct; 165(8):4567-74. PubMed ID: 11035098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
    Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
    Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
    Fonseca CT; Pacífico LG; Barsante MM; Rassi T; Cassali GD; Oliveira SC
    Microbes Infect; 2006 Aug; 8(9-10):2509-16. PubMed ID: 16914349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
    Ricciardi A; Dalton JP; Ndao M
    Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody responses to Schistosoma mansoni schistosomula antigens.
    Egesa M; Lubyayi L; Jones FM; van Diepen A; Chalmers IW; Tukahebwa EM; Bagaya BS; Hokke CH; Hoffmann KF; Dunne DW; Elliott AM; Yazdanbakhsh M; Wilson S; Cose S
    Parasite Immunol; 2018 Dec; 40(12):e12591. PubMed ID: 30239012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of mice against Schistosoma mansoni infection by passive transfer of sera from infected rabbits.
    Fallon PG; Fookes RE; Doenhoff MJ
    Parasite Immunol; 1996 Jan; 18(1):7-14. PubMed ID: 9223151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory--secretory candidate vaccine antigens.
    El Ridi R; Tallima H; Mahana N; Dalton JP
    Microbes Infect; 2010 Sep; 12(10):700-9. PubMed ID: 20452455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of a protective antigen for adjuvant-free immunization against Schistosoma mansoni.
    King CH; Lett RR; Nanduri J; el Ibiary S; Peters PA; Olds GR; Mahmoud AA
    J Immunol; 1987 Dec; 139(12):4218-24. PubMed ID: 3121733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of Sm-p80 in the presence of resiquimod as an adjuvant against challenge infection with Schistosoma mansoni in mice.
    Ahmad G; Zhang W; Torben W; Noor Z; Siddiqui AA
    Int J Infect Dis; 2010 Sep; 14(9):e781-7. PubMed ID: 20630783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.